Circulating calcium concentrations, vascular disease and mortality: A systematic review

Journal of Internal Medicine

Volumn 279, Issue 6, 2016, Pages 524-540

  Reid, I R ^a,b   Gamble, G D ^a   Bolland, M J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Arterial calcification; Death; Myocardial infarction; Stroke; Vascular disease

Indexed keywords

CALCIUM;

ARTERY CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; BLOOD; CALCINOSIS; COMPLICATION; RISK FACTOR; VASCULAR DISEASE;

CALCINOSIS; CALCIUM; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; STROKE; VASCULAR DISEASES;

EID: 84953931406     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12464     Document Type: Review

References (78)

1. Bolland MJ, Avenell A, Baron JA et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: C3691.
2. Bolland MJ, Grey A, Avenell A et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040.
3. Durup D, Jorgensen HL, Christensen J et al. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 2012; 97: 2644-52.
4. Grandi NC, Brenner H, Hahmann H et al. Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart 2012; 98: 926-33.
5. Larsson TE, Olauson H, Hagstrom E et al. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community. Arterioscler Thromb Vasc Biol 2010; 30: 333-9.
6. Walsh JP, Divitini ML, Knuiman MW. Plasma calcium as a predictor of cardiovascular disease in a community-based cohort. Clin Endocrinol 2013; 78: 852-7.
7. Welsh P, Doolin O, McConnachie A et al. Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN family study. J Clin Endocrinol Metab 2012; 97: 4578-87.
8. Reunanen A, Knekt P, Marniemi J et al. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 1996; 50: 431-7.
9. Foley RN, Collins AJ, Ishani A et al. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 556-63.
10. Lutsey PL, Alonso A, Michos ED et al. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2014; 100: 756-64.
11. Jorde R, Schirmer H, Njølstad I et al. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol 2013; 28: 569-78.
12. Jorde R, Sundsfjord J, Fitzgerald P et al. Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 1999; 34: 484-90.
13. Lind L, Skarfors E, Berglund L et al. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997; 50: 967-73.
14. Slinin Y, Blackwell T, Ishani A et al. Serum calcium, phosphorus and cardiovascular events in post-menopausal women. Int J Cardiol 2011; 149: 3350.
15. Øgard CG, Petersen J, Jørgensen T et al. Serum ionised calcium and cardiovascular disease in 45-years old men and women followed for 18 years. Eur J Epidemiol 2006; 21: 123-7.
16. Li J, Wu N, Li Y et al. Cross-sectional analysis of serum calcium levels for associations with left ventricular hypertrophy in normocalcemia individuals with type 2 diabetes. Cardiovasc Diabetol 2015; 14: 43.
17. Leifsson BG, Ahren B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 1996; 81: 2149-53.
18. James MFM, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothor Vasc Anesthes 2004; 18: 581-6.
19. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-9.
20. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-67.
21. Kapustin AN, Davies JD, Reynolds JL et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 2011; 109: e1-12.
22. Shin S, Kim KJ, Chang HJ et al. Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 2012; 33: 2873-81.
23. Dhingra R, Sullivan LM, Fox CS et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879-85.
24. Herrmann M, Schaefer C, Kinkeldey A et al. Ectopic calcification in fetuin-A deficient mice starts in the microvasculature. Bone 2011; 48: S241.
25. Schafer C, Heiss A, Schwarz A et al. The serum protein alpha(2)-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-66.
26. Lomashvili KA, Narisawa S, Millan JL et al. Vascular calcification is dependent on plasma levels of pyrophosphate. Kidney Int 2014; 85: 1351-6.
27. Luo GB, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
28. Cai MM, Smith ER, Holt SG. The role of fetuin-A in mineral trafficking and deposition. Bonekey Rep 2015; 4: 672.
29. House MG, Kohlmeier L, Chattopadhyay N et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997; 12: 1959-70.
30. Hilgard P. Experimental hypercalcaemia and whole blood clotting. J Clin Pathol 1973; 26: 616-9.
31. Yilmaz H. Assessment of mean platelet volume (MPV) in primary hyperparathyroidism: effects of successful parathyroidectomy on MPV levels. Endocr Regul 2014; 48: 182-8.
32. Bristow SM, Gamble GD, Stewart A et al. Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in postmenopausal women. Br J Nutr 2015; 114: 1868-74.
33. De Bacquer D, De Henauw S, De Backer G et al. Epidemiological evidence for an association between serum calcium and serum lipids. Atherosclerosis 1994; 108: 193-200.
34. Fraser A, Williams D, Lawlor DA. Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS ONE 2010; 5: e13882.
35. Park SH, Kim SK, Bae YJ. Relationship between serum calcium and magnesium concentrations and metabolic syndrome diagnostic components in middle-aged Korean men. Biol Trace Elem Res 2012; 146: 35-41.
36. Lind L, Jakobsson S, Lithell H et al. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 1988; 297: 960-3.
37. Kamycheva E, Jorde R, Haug E et al. Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion. Acta Physiol Scand 2005; 184: 113-9.
38. Nilsson IL, Rastad J, Johansson K et al. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001; 130: 986-90.
39. Hagström E, Ahlström T, Ärnlöv J et al. Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort. Atherosclerosis 2015; 238: 420-6.
40. Jin Y, He L, Wang Q et al. Serum calcium levels are not associated with coronary heart disease. Vasc Health Risk Manag 2013; 9: 517-20.
41. Williams DM, Fraser A, Lawlor DA. Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart 2011; 97: 315-20.
42. Rasouli M, Kiasari AM. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo) lipoproteins. Clin Chem Lab Med 2006; 44: 43-50.
43. Hagstrom E, Lundgren E, Lithell H et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol 2002; 56: 251-8.
44. Bollerslev J, Rosen T, Mollerup CL et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94: 2255-61.
45. Lorenzo C, Hanley AJ, Rewers MJ et al. Calcium and phosphate concentrations and future development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetologia 2014; 57: 1366-74.
46. Hagström E, Hellman P, Lundgren E et al. Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 2007; 50: 317-24.
47. Wareham NJ, Byrne CD, Carr C et al. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism 1997; 46: 1171-7.
48. Ahlstrom T, Hagstrom E, Larsson A et al. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol 2009; 71: 673-8.
49. Yu N, Donnan PT, Flynn RWV et al. Increased mortality and morbidity in mild primary hyperparathyroid patients The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol 2010; 73: 30-4.
50. Procopio M, Barale M, Bertaina S et al. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine 2014; 47: 581-9.
51. Stamatelopoulos K, Athanasouli F, Pappa T et al. Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2014; 99: 2704-11.
52. Grey AB, Evans MC, Stapleton JP et al. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med 1994; 121: 745-9.
53. Bolland MJ, Grey AB, Gamble GD et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005; 90: 1525-30.
54. Grey A, Reid I. Body weight and bone mineral density in hyperparathyroidism. Ann Intern Med 1995; 123: 732.
55. Piovesan A, Molineri N, Casasso F et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol 1999; 50: 321-8.
56. Nilsson IL, Aberg J, Rastad J et al. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999; 126: 1049-55.
57. Palmer M, Adami HO, Krusemo UB et al. Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. Am J Epidemiol 1988; 127: 1031-40.
58. Luigi P, Chiara FM, Laura Z et al. Arterial hypertension, metabolic syndrome and subclinical cardiovascular organ damage in patients with asymptomatic primary hyperparathyroidism before and after parathyroidectomy: preliminary results. Int J Endocrinol 2012; 408295. doi:10.1155/2012/408295.
59. Khaleeli AA, Johnson JN, Taylor WH. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab Res Rev 2007; 23: 43-8.
60. Vestergaard P, Mollerup CL, Frøkjær VG et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003; 27: 216-22.
61. Neunteufl T, Heher S, Prager G et al. Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol 2000; 53: 229-33.
62. Bernini G, Moretti A, Lonzi S et al. Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Metabolism 1999; 48: 298-300.
63. Marz W, Seelhorst U, Wellnitz B et al. Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality. J Clin Endocrinol Metab 2007; 92: 2363-9.
64. O'Seaghdha CM, Yang Q, Glazer NL et al. Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. Hum Mol Genet 2010; 19: 4296-303.
65. Bristow SM, Gamble GD, Stewart A et al. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr 2014; 112: 1611-20.
66. Bristow SM, Gamble GD, Stewart A et al. Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy meal on serum calcium and phosphate: a randomised cross-over trial. Br J Nutr 2015; 113: 1585-94.
67. Medicines and Healthcare Products Regulatory Agency (MHRA). Strontium ranelate (Protelos): risk of serious cardiac disorders-restricted indications, new contraindications, and warnings. Drug Saf Update 2013; 6: S1.
68. Lamas GA, Goertz C, Boineau R et al. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction. The TACT randomized trial. JAMA 2013; 309: 1241-50.
69. Van Hemelrijck M, Hermans R, Michaelsson K et al. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study. Cancer Causes Control 2012; 23: 1349-58.
70. Marniemi J, Alanen E, Impivaara O et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005; 15: 188-97.
71. Bolland MJ, Barber PA, Doughty RN et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262-6.
72. Payne ME, Pierce CW, McQuoid DR et al. Serum ionized calcium may be related to white matter lesion volumes in older adults: a pilot study. Nutrients 2013; 5: 2192-205.
73. Narang R, Ridout D, Nonis C et al. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 1997; 60: 73-9.
74. Ishizaka N, Ishizaka Y, Takahashi E et al. Serum calcium concentration and carotid artery plaque: a population-based study. J Cardiol 2002; 39: 151-7.
75. Rubin MR, Rundek T, McMahon DJ et al. Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis 2007; 194: 426-32.
76. Wang TKM, Bolland MJ, van Pelt NC et al. Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J Bone Miner Res 2010; 25: 2501-9.
77. Bolland MJ, Wang TKM, van Pelt NC et al. Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 2010; 25: 505-12.
78. Kwak SM, Kim JS, Choi Y et al. Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 2014; 34: 1763-9.